Since most of the patients become bacilli negative at month 2 when they finish the intensive phase of anti-TB treatment, our results strongly suggest that the generation of IgA-mediated mucosal immunity is largely due to M. tb infection. The gene discussed is CD79A; the disease is tuberculosis.